Company / SG&A per Share
CONMED Corporation SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$18.76
FY2025
5-year range
$12.69 / $18.76
FY2021-FY2025
Trend
+17.9%
vs FY2024
Sector context
#23 of 156
Health Care
What the data says
CONMED Corporation's sg&a per share of $18.76 is higher than 85% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 3 consecutive years, from $12.69 in FY2022 to $18.76 in FY2025.
Based on SEC 10-K filings.
18.76 in FY2025 with a 5-year CAGR of +8.8%. Top quartile in the Health Care sector.
Increased from $15.61 to $18.76 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +13.9%
- 5-Year CAGR
- +8.8%
- 10-Year CAGR
- -
Sector benchmark
-99.8% below sector average
Key checks
Key Insights
- CONMED Corporation's sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 17.9% year-over-year.
- Ranks #23 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.76 | +17.9% |
| FY2024 | $15.92 | +2.0% |
| FY2023 | $15.61 | +23.1% |
| FY2022 | $12.69 | -6.5% |
| FY2021 | $13.57 | +10.2% |
| FY2020 | $12.31 | -1.4% |
| FY2019 | $12.49 | +3.2% |
| FY2018 | $12.10 | +11.2% |
| FY2017 | $10.88 | -6.6% |
| FY2016 | $11.65 | +8.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026